 Karuna Therapeutics NASDAQ:KRTX CFO Troy A. Ignelzi sold 6,000 shares of the businesss stock in a transaction dated Monday, June 15th. The shares were sold at an average price of 89.75, for a total value of 538,500.00. Following the completion of the sale, the chief financial officer now owns 2,000 shares in the company, valued ... 